HomeGLABF • OTCMKTS
add
Gemina Laboratories Ltd
Previous close
$0.42
Year range
$0.24 - $0.63
Market cap
45.49M CAD
Avg Volume
9.98K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 821.82K | -5.75% |
Net income | -864.18K | 26.02% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -749.34K | 13.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 41.61K | 1,336.38% |
Total assets | 1.53M | -9.08% |
Total liabilities | 4.99M | 112.14% |
Total equity | -3.46M | — |
Shares outstanding | 74.51M | — |
Price to book | -8.40 | — |
Return on assets | -135.72% | — |
Return on capital | 118.36% | — |
Cash Flow
Net change in cash
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Net income | -864.18K | 26.02% |
Cash from operations | -176.09K | 35.51% |
Cash from investing | — | — |
Cash from financing | 10.85K | -93.73% |
Net change in cash | -165.23K | -47.32% |
Free cash flow | 103.61K | 215.38% |
About
Founded
2017
Headquarters
Website
Employees
6
